Navigation Links
Apollo Endosurgery Completes First-in-Human Cases With New OverStitch™ Endoscopic Suturing System
Date:10/28/2010

AUSTIN, Texas, Oct. 28 /PRNewswire/ -- Apollo Endosurgery, Inc. announced that their newly-launched OverStitch™ Endoscopic Suturing System has recently been employed in several, first-in-human cases.

OverStitch Endoscopic Suturing System is a unique device that mimics the way physicians deploy sutures by hand.  It provides full-thickness endoscopic suturing on a flexible platform, delivering surgical standard of care through the flexible endoscope.  

OverStitch was first used by Dr. Santiago Horgan at University of California, San Diego (UCSD) in a patient who had been suffering from multiple complications due to a gastric fistula, otherwise described as a "leak in the stomach". The OverStitch Endoscopic Suturing System was deployed endoscopically to facilitate the closure of the fistula.Dr. Christopher Gostout has since used the device at the Mayo Clinic (Rochester, MN) to repair an esophageal fistula.  The OverStitch Endoscopic Suturing System was utilized to place multiple sutures that effectively closed the fistula.  Dr. Gostout was ecstatic and said "the device worked flawlessly in the esophageal environment".  He further said "The device will address a wide variety of previously unmet needs for tissue apposition throughout the GI tract".

"The early reception of the OverStitch product has been exceptional; we are very excited to see our products providing clinicians the ability to offer less invasive endoscopic surgical treatment options" noted Lee Putman, Apollo Endosurgery Vice President of Sales & Marketing. "The OverStitch product provides Apollo an excellent opportunity to advance the potential of flexible surgery, while improving patient outcomes and lives".  Aiding this advancement, Apollo has created its Gemini (Gastrointestinal Endoscopic MINimally Invasive) Suturing Registry. The registry provides a tool whereby data can be collected and maintained from each case where the OverStitch product is employed.

About Apollo Endosurgery, Inc.Apollo Endosurgery, Inc. is dedicated to revolutionizing patient care through the development of flexible surgery, which is emerging from the convergence of laparoscopic surgery and therapeutic gastroenterology.  Flexible surgery minimizes the trauma of surgical access by taking advantage of natural orifices to deliver surgical tools to targeted areas.  All of Apollo's products are compatible with existing flexible endoscope platforms.  Apollo Endosurgery was co-founded with the Apollo Group, a unique collaboration of physicians from the Mayo Clinic, Johns Hopkins University, Medical University of South Carolina, the University of Texas Medical Branch and the Chinese University of Hong Kong.  The company is funded by PTV Sciences and H.I.G. Ventures.  

For more information, visit our website (www.apolloendo.com) or contact:Ted StephensDirector of MarketingApollo Endosurgery, Inc.512-328-9990 (o)513-312-9161 (m)
'/>"/>

SOURCE Apollo Endosurgery, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Apollo Endosurgery Completes First Clinical Case with Newly-Launched FlexShears™ Endoscopic Scissors
2. Boston Scientific Completes Acquisition of Asthmatx
3. Warner Chilcott Completes Acquisition of U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
4. Highland Capital Management Announces 100% Ownership of American HomePatient, Completes Successful Public to Private Transition For Leading Provider of Home Respiratory Therapy
5. Incept BioSystems Completes First Human Clinical Trial of the SMART Start™ Embryo Culture System and Submits 510(k) Application to the FDA
6. InfraReDx Completes $21 Million Equity Financing
7. Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
8. Randomized Clinical Trial of OrbusNeichs Genous™ Bio-engineered R stent™ in China Completes Patient Enrollment
9. DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial
10. IDEV Technologies Completes $46 Million Preferred Stock Financing With Piper Jaffray and Additional Strategic Investor
11. SAFC® Completes Expansion of High-Potency Fermentation Capabilities at Israel Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... , May 31, 2016 ... Market by Product (Scanners, Software), by Type (Human, Animal ... by Application (Teleconsultation, Drug Discovery) - Global Forecasts to ... Market for the forecast period of 2016 to 2021. ... by 2021 from USD 384.3 Million in 2016, at ...
(Date:5/31/2016)... 31, 2016 The global dental ... at a CAGR of 10.6% within a forecast period ... US$0.46 bn in 2013. Owing to favorable factors at ... US$0.88 bn by the end of this forecast period, ... market,s holistic representation in a research report published by ...
(Date:5/31/2016)... 2016 PaperHive Will Enable ... Elsevier,s ScienceDirect Database Elsevier , ... information products and services, today announced it will ... collaboration platform PaperHive to enable researchers to easily discover, ... on ScienceDirect , the world,s largest database ...
Breaking Medicine Technology:
(Date:5/31/2016)... (PRWEB) , ... May 31, ... ... to healthcare that considers individuals’ genetic characteristics and the physical and behavioral ... therapy work in sync. In personalized medicine, diagnosing an individual’s disease depends ...
(Date:5/31/2016)... TEXAS (PRWEB) , ... May 31, 2016 , ... ... live in Greater Houston Healthconnect’s (Healthconnect) regional health information exchange, which enables physicians ... medical records for their patients from other participating organizations in the exchange. SJMC’s ...
(Date:5/31/2016)... , ... May 31, 2016 , ... ... calls back to particular advertising campaigns, to monitor the performance of sales and ... can maximize conversions and revenue. The software allows customers to record, transcribe, route, ...
(Date:5/31/2016)... ... May 31, 2016 , ... The Global Wellness ... released ten predictions on the future of wellness, travel, spa and beauty in Europe. ... spa and beauty companies to leading economists and researchers - to forecast where wellness ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Interest is on ... screening tool and as an orthogonal tool for RNAi hit validation. A key reason ... specific guide RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed formats. ...
Breaking Medicine News(10 mins):